Swollen breast tissue in men is rarely just a cosmetic inconvenience. When a patient walks into a clinic asking about gynecomastia surgery in Mumbai, the most important conversation doesn’t begin with surgical technique — it begins with a simple question: why did this tissue grow in the first place?
Skipping that question is precisely why a meaningful number of patients end up back in the surgeon’s chair within two to three years, dealing with tissue that has returned, sometimes more aggressively than before.
Why Gynecomastia Comes Back After Surgery
Gynecomastia is driven by an imbalance between estrogen and androgen activity in breast tissue. Surgery removes the physical result of that imbalance — the glandular tissue and, in some cases, excess fat — but it does not touch the hormonal environment that created it. If that environment remains uncorrected, the residual or regenerating glandular cells respond to the same signals and tissue gradually returns.
The most common hormonal culprits that must be evaluated before any operation include:
– Elevated estradiol — either from primary testicular dysfunction, peripheral aromatization in excess adipose tissue, or an estrogen-secreting tumour
– Low testosterone — whether due to hypogonadism, pituitary suppression, or anabolic steroid misuse followed by crash periods
– Elevated prolactin — a pituitary adenoma (prolactinoma) raises prolactin, which suppresses testosterone and independently stimulates breast tissue
– Thyroid dysfunction — both hyperthyroidism and hypothyroidism alter sex hormone-binding globulin (SHBG) levels, shifting the free estrogen-to-androgen ratio
– Elevated hCG — a marker that can point to a testicular germ cell tumour, one of the more serious and time-sensitive causes a surgeon must rule out before scheduling any elective procedure
– Liver enzyme abnormalities — impaired hepatic clearance of estrogens amplifies estrogenic activity even when production is normal
According to guidance published by the Endocrine Society, a structured hormonal workup is considered standard of care before labelling any case of gynecomastia as idiopathic and proceeding with surgical correction. Operating without this data is, clinically speaking, a gamble — and the patient absorbs the consequences.
Medication review matters equally. Spironolactone, certain antipsychotics, proton pump inhibitors taken long-term, and several cardiac drugs are well-documented causes of drug-induced gynecomastia. So is recreational cannabis and, paradoxically, exogenous testosterone when aromatization is not managed. A thorough drug and supplement history should accompany every hormone panel.
What a Responsible Pre-Surgical Workup Looks Like
A well-structured evaluation ahead of gynecomastia surgery in Mumbai should include at minimum: serum testosterone (total and free), estradiol, LH, FSH, prolactin, hCG, TSH, and a liver function panel. In younger patients — particularly those under 25 — a scrotal ultrasound is a reasonable addition given the association between adolescent or young-adult gynecomastia and testicular pathology.
This isn’t bureaucratic box-ticking. Each test answers a specific question:
Testosterone and LH/FSH Together
These distinguish between primary hypogonadism (low testosterone, high LH/FSH — the testes are the problem) and secondary hypogonadism (low testosterone, low or inappropriately normal LH/FSH — the hypothalamus or pituitary is the problem). The treatment pathway, and therefore the surgical timing, differs substantially between the two.
Prolactin and Estradiol
An elevated prolactin with a normal estradiol pattern points toward a pituitary cause. An isolated estradiol elevation in the context of normal gonadotropins raises concern for an estrogen-secreting adrenal or testicular source. Both require investigation and, in some cases, treatment before surgery is appropriate.
Liver Function Tests
Hepatic causes of gynecomastia are underappreciated. Cirrhosis, non-alcoholic fatty liver disease with significant fibrosis, and certain hepatotoxic medications all impair estrogen metabolism. Correcting or managing the hepatic issue first can sometimes reduce tissue volume enough to simplify — or in rare cases eliminate the need for — surgery.
When bloodwork reveals a correctable cause, addressing it first is not a delay tactic; it is the treatment. Prolactinomas respond well to dopamine agonists. Thyroid disorders are managed medically. Drug-induced cases often resolve partially or fully after the offending agent is withdrawn. Only after the hormonal environment is either normalised or confirmed stable and non-correctable should surgical removal of residual tissue be planned.
Patients who receive this structured approach consistently have better long-term outcomes. Those who are taken straight to theatre without workup are, statistically, more likely to be back — not because the surgeon’s technique was poor, but because the underlying drive for tissue growth was never addressed.
For anyone considering gynecomastia surgery in Mumbai, the right first appointment is one where bloodwork is discussed before operative planning begins. A surgeon who hands you a pre-operative lab request form at your first consultation is demonstrating exactly the kind of clinical rigour you should be looking for. According to Mayo Clinic’s overview of gynecomastia, identifying and treating underlying causes is the foundational step before any intervention — surgical or otherwise.
The tissue doesn’t grow for no reason. Find the reason first.
Frequently Asked Questions
What blood tests are needed before gynecomastia surgery in Mumbai?
At minimum: total and free testosterone, estradiol, LH, FSH, prolactin, hCG, TSH, and a liver function panel. Younger patients may also need a scrotal ultrasound. These tests identify hormonal causes that, if left untreated, lead to recurrence after surgery.
Can gynecomastia come back after surgery?
Yes, it can — particularly when the underlying hormonal cause has not been identified and corrected before the operation. Surgery removes existing tissue but does not alter the hormonal environment driving growth. Without pre-surgical bloodwork, recurrence rates are significantly higher.
How long should I wait after fixing a hormonal cause before having surgery?
This depends on the specific cause. Drug-induced gynecomastia may require three to six months off the offending medication before reassessment. Hormonal conditions such as hyperthyroidism or hyperprolactinaemia should be medically stabilised and confirmed with repeat labs before surgical planning proceeds.
Is gynecomastia surgery safe if I’m on testosterone replacement therapy?
Not without additional precautions. Exogenous testosterone can aromatise into estradiol, which may worsen or perpetuate gynecomastia. Operating while this remains unmanaged — without an aromatase inhibitor strategy or dose adjustment — risks recurrence. Your surgeon and endocrinologist should align on a plan before any procedure.
What if my bloodwork is normal but I still have breast tissue?
Normal bloods at a single time point don’t always capture dynamic hormonal fluctuations. If history and presentation strongly suggest a hormonal component, repeat testing or specialist referral is warranted. If results are consistently normal, the gynecomastia may be classified as idiopathic or residual from a prior cause, and surgery is then appropriate.
How do I find a surgeon in Mumbai who does proper pre-surgical evaluation?
Look for a surgeon who requests a full hormone panel and medication review at the first consultation — not one who moves directly to quoting surgical fees. Board certification, before-and-after case transparency, and a willingness to co-manage with an endocrinologist when indicated are all positive signs.